Prescriber's Letter | Unbiased Medication Updates & CME

Current Issue

April 2025 Issue

Be Ready if a Measles Outbreak Hits Your Community

Recent headlines will spur questions about managing measles...

Resources

Algorithm: Vaccine Adherence: Addressing Myths and Hesitancy
FAQ: Vaccinating Immunocompromised Patients

Nip Allergic Rhinitis in the Bud

Spring is here...

Watch for Tirzepatide for Sleep Apnea

Tirzepatide (Zepbound) will be the first Rx med approved to treat moderate to severe obstructive sleep apnea (OSA) in adults...

Minimize Multiple Anticholinergics in Older Patients

You’ll see renewed focus on limiting anticholinergic medications in older adults...

GO TO FULL ISSUE

CE & Training

NEW REQUIRED COURSE: Substance Use Disorders and Pain Management: MATE Act Training

CE-IN-THE-LETTER: Prescriber Insights April 2025

LIVE CE: Dementia Medications: Balancing the Risks and Benefits

PODCAST CE: Medication Talk - Cardiovascular Impact of Diabetes Meds

GO TO CE & TRAINING ORGANIZER

Featured Clinical Resources

GO TO ALL CLINICAL RESOURCES >

What is Prescriber Insights?

Prescriber Insights is the fastest, most trustworthy way for physicians, APRNs, and PAs to find out how drug therapy changes should fit into your practice. It's unbiased, evidence-based, and 100% free from financial support of the pharma industry. Learn more >

Group Purchases & Pricing

Prescriber Insights is eligible for bulk discounts. Customize CE and compliance training assignments. Easily manage users and run reports. Bundle with other products for significant savings. Request information

Welcome to Your Prescriber Insights

We value you and hope you take advantage of all the features of your subscription. For example, ask medication therapy questions and provide answers alongside your colleagues in the Forum.